Skip to content

Clinical trials

Phase 2 Coronary Artery Disease trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 2 Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20071
20082
20091
20112
20131
20142
20221
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status5
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
King's College London2
Novartis Pharmaceuticals2
University of Oxford2
Biopure Corporation1
Bristol-Myers Squibb1
Gilead Sciences1
Medlogics Device Corporation1
Micell Technologies1
OrbusNeich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease15
Angina, Stable3
Myocardial Infarction3
Atherosclerosis2
Heart Diseases2
Acute Coronary Syndrome1
Coronary Disease1
Diabetes Mellitus1
Thrombosis1
Vascular Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.